US FDA Panel Sees Benefits To OTC Pathogen Tests, But Urges Caution
Executive Summary
An FDA panel concluded Aug. 16 that the benefits of over-the-counter tests for influenza, strep throat and certain sexually transmitted infections would likely outweigh the risks. But the group urged developers to take care in ensuring that the test results were easy for patients to interpret.
You may also be interested in...
OTC Tests For Flu, Strep, STIs Up For Discussion At FDA Panel Meeting
Panelists will look at the benefits and risks of over-the-counter diagnostics for influenza, strep throat and sexually transmitted infections. The meeting is being held in response to sponsor queries about new test designs.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
FDA Leader Looks To International Effort On Pediatric Device Development
Collaboration with Japan and Europe could help ease the development path for pediatric devices, cardiovascular device office director Bram Zuckerman said at a recent conference. Zuckerman also spoke on other cardiac device priorities at the FDA.